Medical Decision Modeling Inc. (MDM) was founded in 1996 to develop, analyze, and successfully communicate scientifically-defensible health and economic value messages for our client's external and internal stakeholders.There are three main products and services offered to clients world-wide: (1) The development of sophisticated interactive pharmacoeconomic software models including extensive experience with discrete-event and micro simulation models, (2) The production of evidence-based pharmaceutical reimbursement dossiers, and (3) The analysis of electronic claims and medical records databases for our clients.The types of work that MDM is contracted to provide for clients includes:-- Cost-Effectiveness Models-- Budget Impact Models-- Global and US-focused reimbursement dossiers-- Systematic Literature Reviews-- Manuscript development for publication of contracted research-- Auditing of pharmaceutical models developed by other consultants-- Reverse engineering of published models to analyze the validity of assumptions and resultsMDM clients include:-- Pharmaceutical companies (top 100 worldwide)-- Entrepreneurially-focused pharmaceutical companies (single to few lines)-- Biotechnology-- Diagnostic and device companies-- University-based academic researchersThrough 2010, MDM has 41 diseases and/or disorders in its work portfolio and MDM has received six (6) NIH SBIR grants since 1996.